FdaApplication
NDA 207131
Identifiers
- fda_app_no: NDA207131
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 2015-08-07 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CEFAZOLIN IN DEXTROSE | CEFAZOLIN SODIUM | EQ 3GM BASE/150ML (EQ 20MG BASE/ML) | SOLUTION;INTRAVENOUS |
| CEFAZOLIN IN DEXTROSE | CEFAZOLIN SODIUM | EQ 1GM BASE/50ML (EQ 20MG BASE/ML) | SOLUTION;INTRAVENOUS |
| CEFAZOLIN IN DEXTROSE | CEFAZOLIN SODIUM | EQ 2GM BASE/100ML (EQ 20MG BASE/ML) | SOLUTION;INTRAVENOUS |
3 products